SYNOPSIS Results of the 57Co vitamin B12 plasma level absorption test are described in 163 patients. The use of intramuscular carbachol with the test and the presence or absence of current vitamin B12 therapy did not affect the test results. Injection of 1,000 yg of unlabelled vitamin B12 during the test augmented plasma levels in patients with normal absorption but tests without this injection gave satisfactory differentiation between the normal and malabsorption ranges. Results from patients having had a gastrectomy, ileal resection, or a past history of adult coeliac disease are also described. Amongst patients with presumed Addisonian pernicious anaemia, two with unresolved equivocal results and three with falsely normal results were found. The significance of these is discussed.
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Vitamin B12 absorption tests based on the measurements of plasma levels of labelled vitamin B12 have been described by several groups (Booth and Mollin, 1956; Goldberg, Trivedi, and Oliner, 1957; Kristensen and Hald, 1962; Nelp, McAfee, and Wagner, 1963; Doscherholmen, 1965; McCurdy, 1965; Coupland, 1966; Workman and Rusche, 1966; Forshaw and Harwood, 1966 Woodliff and Armstrong, 1966; Armstrong and Woodliff, 1967; Armstrong and Woodliff, 1969 
Results
The results of the absorption tests are set out in Tables I to III In patients with vitamin B12 malabsorption presumed on clinical data or proven to be due to intrinsic factor deficiency (Table I) , the difference between the means of tests performed with carbachol and hydroxocobalamin intramuscularly, with hydroxocobalamin alone, and with neither injection are not significant. Nor were the differences significant between means of those patients receiving and those not receiving parenteral vitamin B12 therapy at the time of testing. Of the tests with intramuscular hydroxocobalamin, four results were equal to or greater than 0-45% (0-47%, 0-49%, 0-58%, 0-59%). All were less than 0-45% on repeat testing. Of the tests without intramuscular hydroxocobalamin, three were equal to or greater than 0-30 % (0-31%, 0-34%, and 0-35%). All were less than 0-30 % on repeat testing.
In patients with normal vitamin B12 absorption (Table II) The differences between means are not significant. Adding intrinsic factor gave a rise of more than 0-20 % on the part 1 plasma level in all cases. Eighteen tests were done on 13 postgastrectomy patients. Of 11 done with intramuscular hydroxocobalamin the range was 0-05-0-94 %, five were less than 0-45 %, two equivocal, and four greater than 0-60%. Of the seven done without intramuscular hydroxocobalamin, the range was 0-05-1-8%; five were less than 0-30% and two greater than 0-45 %.
Five patients with adult coeliac disease in remission were studied. One showed malabsorption (0-25 %), one equivocal absorption (0-32% in a test without intramuscular hydroxocobalamin), and three normal absorption (1-6%, 0-81 %, 0-91 %). Two patients known to have had ileal resections showed malabsorption (in part 1 0-04%, 0-18 %) uncorrected by intrinsic factor (in part 2 0-03 %, 0-11 %).
Two patients had unresolved equivocal results. One, D.K., previously referred to ), had a serum B12 level of lessthan40pg/ml,a megaloblastic marrow, and an abnormal Schilling test five years before testing.
Studies on the 57CO vitamin B12 plasma level absorption test
His results with intramuscular hydroxocobalamin were 056 % and 057 %. The second patient had an absorption test result of 0-42 % of the dose per litre of plasma, a serum B12 level of 160 pg/ml (normal range 160-875 pg/mi), and proven gastric carcinoma.
Six tests gave normal results in three patients suspected for other reasons to have pernicious anaemia. One patient, V.P. previously referred to , had achlorhydria, gastric atrophy, and an abnormal Schilling test with three normal plasma levels in tests with intramuscular hydroxocobalamin (0 92 %, 2-0 %, 1 1 %). Another, F.G., lhad normal 57Co vitamin B12 plasma levels with and without intramuscular hydroxocobalamin (0-96 %, 1-34 %) but a serum vitamin B12 level of less than 40 pg/ml, a megaloblastic marrow, and an abnormal Schilling test four years before testing. The third, E.W., had a normal result with intramuscular hydroxocobalamin (0-74%), an equivocal and then an abnormal result without intramuscular hydroxocobalamin (0 34 %, 0-27 %), a serum vitamin B12 level of less than 50 pg/ml, positive parietal cell and intrinsic factor antibody tests, and low urinary excretion of 57Co vitamin B12-6 % of the dose in 48 hours (McCurdy, 1965; McIntyre and Wagner, 1966) . McIntyre and Wagner (1966) found a 31 % incidence of false normals if the lower limit of normal was set at 0 25 % of the dose per litre and 7 % if the lower limit of normal was set at 0-65 % of the dose per litre. On our criteria, three out of 88 (3 4%) patients in our series with vitamin B12 malabsorption gave falsely normal results. Thus we have not found this problem to be as great as did McIntyre and Wagner (1966) , and consider that, provided the absorption test results are always interpreted in the light of other clinical and laboratory data and equivocal tests are repeated, it is unlikely to lead to misdiagnosis.
We cannot offer an explanation for the discrepant results.
In its simplest form, the 57Co vitamin B12 absorption test has the advantage of ease of performance and the avoidance of premature therapy with vitamin B12 and of the errors introduced by urine collection. These must be balanced against the small number of tests repeated because of equivocal results and the smaller number of falsely normal results. We consider the test to be satisfactory for routine use.
